Fig. 3: Patient engraftment after briquilimab-containing conditioning and allo-HSCT. | Nature Medicine

Fig. 3: Patient engraftment after briquilimab-containing conditioning and allo-HSCT.

From: Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial

Fig. 3

a–c, All three patients promptly engrafted neutrophils (a), platelets (b) and RBCs (c) within 2 weeks of HSCT with resolution of earlier cytopenia. d,e, Near-complete multilineage donor chimerism at both short- and long-term timepoints post-HSCT in peripheral blood (PB) (d) and bone marrow (BM) (e). Data are presented as mean ± s.e.m. Each data point represents the average of measurements from three patients.

Back to article page